LAVAL, Quebec, May 10, 2018 /PRNewswire/ -- Valeant
Pharmaceuticals International, Inc. (NYSE/TSX: VRX) ("Valeant")
today announced that Joseph C. Papa,
chairman and chief executive officer, and Arthur J. Shannon, senior vice president and
head of Investor Relations and Communications, are scheduled to
participate at the Bank of America Merrill Lynch Healthcare
Conference in Las Vegas on
May 16, 2018 at 10:40 a.m. PDT (1:40 p.m.
EDT).
A live webcast and audio archive of the event will be available
on the Investor Relations page of the Valeant web site at:
http://ir.valeant.com/events-and-presentations/2018.
About Valeant
Valeant Pharmaceuticals International,
Inc. (NYSE/TSX: VRX) is a global company whose mission is to
improve people's lives with our health care products. We develop,
manufacture and market a range of pharmaceutical, medical device
and over-the-counter products, primarily in the therapeutic areas
of eye health, gastroenterology and dermatology. We are delivering
on our commitments as we build an innovative company dedicated to
advancing global health. More information can be found at
www.valeant.com.
Investor
Contact:
|
Media
Contact:
|
Arthur
Shannon
|
Lainie
Keller
|
arthur.shannon@valeant.com
|
lainie.keller@valeant.com
|
(514)
856-3855
|
(908)
927-0617
|
(877) 281-6642 (toll
free)
|
|
View original content with
multimedia:http://www.prnewswire.com/news-releases/valeant-to-participate-at-2018-bank-of-america-merrill-lynch-healthcare-conference-300645622.html
SOURCE Valeant Pharmaceuticals International, Inc.